LIMS Publications

Home Resources LIMS Publications
Integrating AI and Biobank Management LIMS Systems for Ethical, High-Quality Biobanking

Author: Shonali Paul

Journal: Biobanking.com, February 18, 2025

Abstract: Artificial Intelligence (AI) is rapidly emerging as a transformative technology in data-driven fields such as biobanking and biomedical research. While AI holds immense potential to accelerate discoveries and optimize processes, it also introduces complex ethical and legal challenges.

Bridging the Gap Between Sample Annotation and Research Breakthroughs with a Biospecimen Tracking and Management System

Author: Shonali Paul

Journal: Biobanking.com, October 28, 2024

Abstract: Proper sample annotation is the backbone of successful research. When you accurately document each sample’s details, from collection methods to patient history, you are giving your research the context it needs to yield reliable and meaningful results.

Blood Banking: Navigating Challenges, Best Practices, and the Role of a Blood Bank Management Solution

Author: Shonali Paul

Journal: Biobanking.com, May 01, 2024

Abstract: While it may sound somewhat alliterative, blood banks indeed are the lifeblood of any medical system. Each year, nearly 5 million individuals rely on blood transfusions to sustain their lives, according to the American Red Cross.

Green Tech for Greener Biobanking: How Biobank Software Leads the Decarbonization Drive

Author: Montserrat Valdes

Journal: Astrix, August 25, 2023

Abstract: The need for decarbonization is becoming increasingly urgent as the world grapples with the severe consequences of climate change. With growing emphasis on reducing carbon emissions across various industries, it is inevitable that the energy-intensive nature of biobanks,

Building a Greener Future: Biobank Information Management Systems as Catalysts for Environmental Sustainability

Author: Montserrat Valdes

Journal: Technology Networks, August 14, 2023

Abstract: In the quest for a sustainable future, the urgency for decarbonization has extended its reach to various industries, including biobanking. As global movements emphasize the importance of reducing carbon emissions, the energy-intensive nature of biobanks is coming under scrutiny.

Driving Decarbonization in Biobanking for Environmental Sustainability with a Biorepository Management System

Author: Shonali Paul

Journal: Biobanking.com, June 19, 2023

Abstract: Biobanks offer great potential to researchers by saving them the effort and resources required to gather, store, and manage samples and data. Through the pooling of extensive data sets, known as “big data,” researchers can tackle crucial questions about public health on a local and global scale.

ISO 20387:2018: The Key to Quality Biobanking

Author: Shonali Paul

Journal: Biobanking.com, August 29, 2022

Abstract: In the last two decades, clinical research has grown exponentially; therefore, the demand for high-quality biological samples has increased, not to mention the last two years. The most recent pandemic has accelerated the need to optimize and automate processes to meet the evolving needs of modern research, especially in fields such as genomics, proteomics, precision medicine, and clinical research.

Digitization: Enabling Biobanks Navigate Through Regulatory Challenges

Author: Shonali Paul

Journal: Biobanking.com, March 7, 2022

Abstract: Over the past two decades, there has been an increased need for collecting, curating, storing, and distributing biological specimens to gain specific information into the genetic makeup of diseases [1]. This has sparked the demand for biobanking.

Disease-Specific Biobanks: How Can a LIMS Help in Data Management?

Author: Shonali Paul

Journal: Biobanking.com, October 3, 2021

Abstract: Biobanks have a fundamental role to play in ensuring successful outcomes in clinical research by providing quality biosamples. They host donations of biological materials such as cells, DNA, and tissues. They also handle data that is related to the biosamples.

Safeguarding Viability and Efficacy of COVID-19 Vaccines: Key Considerations

Author: Shonali Paul

Journal: Technology Networks, July 7, 2021

Abstract: While getting vaccinated against COVID-19 is not a guarantee that one will not get infected or re-infected by the virus, it is definitely among the most effective ways to forestall the pandemic. COVID-19 vaccines bolster the immunity of vaccinated individuals and when conducted en masse it helps to provide herd immunity. Consequently, vaccine development and deployment is a top priority for most governments at this point.

Biobanks – A Platform for Modern Biomedical Research

Author: Shonali Paul

Journal: Biobanking.com, April 16, 2021

Abstract: Without biomedical research, medicine, as we know it, would be nothing more than a machine gun affair. In simpler words, biomedical research is the substratum that supports evidence-based medicine. Biomedical researchers study biological and pathological processes in order to prevent and treat disease effectively.

Struggling to Zero in on a Biobanking LIMS? Here is the Checklist of Essential Features To Consider

Author: Shonali Paul

Journal: Technology Networks, February 25, 2021

Abstract: This year, more than ever, has underscored the critical services that biobanks provide to biomedical researchers and other scientists. Biobanks are complex operations that manage thousands, or even millions, of biological samples and associated data required for scientific research.

Data Sharing Solutions for Biobanks for the COVID-19 Pandemic

Authors: Shonali Paul and Mrinal Kanti Chatterjee

Journal: Biopreservation and Biobanking (BIO)
August 19, 2020; Mary Ann Liebert, Inc.; DOI: 10.1089/bio.2020.0040

Abstract: The coronavirus disease 2019 (COVID-19) is a novel illness, which is not fully understood. Whether an individual has traveled outside their respective country or never left their community,

Safety for Biobanks: Strategies for Safe COVID-19 Specimens Handling

Author: Shonali Paul

Journal: Biobanking.com, April 24, 2020

Abstract: The COVID-19 pandemic has spread to almost every country around the world. In less than 4 months, this new disease has affected more than 1,800,000 people and caused almost 120,000 deaths. There are no effective treatments or vaccines for COVID-19. Therefore, while scientists search for therapeutic options, many governments have turned to patient testing and contract tracing to control the outbreak.

ISBER Best Practices Recommendations for Biobanks and Biorepositories

Author: Shonali Paul

Journal: Biobanking.com, March 16, 2020

Abstract: Biorepositories provide essential support to biomedical researchers by collecting, processing, storing and distributing millions of biospecimens every year. Biorepository staff must navigate complex international regulatory rules governing the use of biospecimens and protected health information. The International Society for Biological and Environmental Repositories (ISBER) aims to make this easier with it’s comprehensive Best Practices Recommendations for Biorepositories.

LIMS Evaluation Guide – 10 Pointers Ahead

Author: Shonali Paul

Journal: Biobanking.com, October 29, 2019

Abstract: The primary objective of a biobank is to provide efficient management of samples and their associated data and thus saving valuable time and effort of researchers. Samples without accurate and reliable data may yield insignificant outcomes and therefore, not useful for research. Thus, it is important to maintain a complete chain-of-custody of the samples along with their non-identifiable subject information. Biobanks offer high-quality samples with well-documented procedures to ensure that the samples are stored in a controlled environment.

3 Top Cloud-Based LIMS for Biobanks

Author: Shonali Paul

Journal: Biobanking.com, August 8, 2019

Abstract: A biobank is an entity that stores high-quality biospecimens along with their clinical data such as demographic information, personal medical history, and lifestyle information. Biobanks also ensure that biological specimens are kept in a controlled environment and guarantee that they are collected complying with ethical and legal regulations.

Biospecimen Quality in Clinical Research

Author: Shonali Paul

Journal: Biobanking.com, February 11, 2019

Abstract: Biospecimens form an integral part of many clinical research studies. The production of valid clinical data sets depends largely upon the quality of biospecimens utilized in the study. Annotations of biospecimens help unveil information related to disease prognosis, diagnosis, and treatment. However, there are several stages including collection, processing, and storage through which a biospecimen travels before its utilization in research.

Reasons for Choosing a SaaS LIMS for a Biobank

Author: Shonali Paul

Journal: Biobanking.com, November 5, 2018

Abstract: With the growing acceptance of LIMS by laboratories, there also exists a continuous dilemma on how to zero-in on a LIMS that is efficient, flexible, and scalable to accommodate the changing needs of a laboratory with time. A traditional on-premise LIMS requires a dedicated IT infrastructure, a skilled team of software programmers, and has a high cost and long deployment period.

The State of Cloud-Based Biospecimen and Biobank Data Management Tools (BRIEF REPORT)

Authors: Shonali Paul, Aditi Gade, and Sumani Mallipeddi

Journal: Biopreservation and Biobanking (BIO)
Volume 15, Number 2, 2017; Mary Ann Liebert, Inc.; DOI: 10.1089/bio.2017.0019

Abstract: Biobanks are critical for collecting and managing high-quality biospecimens from donors with appropriate clinical annotation. The high-quality human biospecimens and associated data are required to better understand disease processes. Therefore, biobanks have become an important and essential resource for healthcare research and drug discovery.

Breaking the Lab Shopping Cycle

Author: Arun Apte

Journal: The Cannabis Scientist, August 18, 2023

Abstract: The wave of cannabis legalization in the US has resulted in a rapid expansion of the industry – predicted to reach $82.3 billion by 2027 (1). Various cannabis-related enterprises are emerging, from businesses focused on processing, testing, and distribution of cannabis products to those providing legal, financial, and consulting services.

Breaking the Cycle: Effective Strategies for Cannabis Testing Labs and Regulators to Address THC Inflation and Lab Shopping

Author: Montserrat Valdes

Journal: Astrix, July 25, 2023

Abstract: The legalization of cannabis in different states in the US has resulted in a rapid expansion of the industry.It is predicted that the regulated cannabis industry will reach $82.3 billion by 2027.

Navigating ISO/IEC 17025: Key Considerations for Cannabis Lab Software

Author: Montserrat Valdes

Journal: Cannabis Industry Journal, July 04, 2023

Abstract: In some states, cannabis testing facilities must undergo a third-party audit as a condition for obtaining their license. This may involve obtaining an ISO/IEC 17025 accreditation, which requires an evaluation from a qualified auditor.

THC Inflation and Lab Shopping: Strategies for Cannabis Labs and Regulators

Author: Arun Apte

Journal: Labcompare, June 30, 2023

Abstract: The unstoppable surge of the regulated cannabis industry in the United States has been nothing short of phenomenal. With the legalization of cannabis in different states, this budding industry is expected to bloom and reach a staggering $82.3 billion by 2027.

The Rising Threat to the US Cannabis Industry: How THC Inflation and Laboratory Shopping are Undermining Trust

Author: Arun Apte

Journal: Cannabis Science and Technology, June 21, 2023

Abstract: A tutorial article that delineates the rising threats of “lab shopping” and THC inflation to the US cannabis industry and proposes solutions to overcome them.

How Cannabis Testing Labs Can Navigate ISO 17025 Accreditation

Author: Arun Apte

Journal: Labcompare, June 06, 2023

Abstract: Even though some states in the U.S. have made cannabis legal, it’s still against federal law. This means that the rules and regulations for cannabis-related businesses are different from state to state.

Stemming the Tide: Strategies for Cannabis Testing Labs & Regulators to Address THC Inflation and Lab Shopping

Author: Arun Apte

Journal: Cannabis Industry Journal, May 24, 2023

Abstract: The cannabis industry in the United States is booming. In just a few years, it has gone from a small, underground market to a multi-billion-dollar industry. This growth is due in part to the legalization of cannabis in many states, as well as the growing public acceptance of its use for both medical and recreational purposes.

Demystifying ISO 17025 Requirements for Cannabis Testing Labs: A Step-by-Step Guide

Author: Arun Apte

Journal: Analytical Cannabis, April 26, 2023

Abstract: Although many states in the United States have legalized or decriminalized cannabis, it remains illegal at the federal level. As a result, regulations surrounding cannabis businesses vary significantly from state to state. In certain states, cannabis testing facilities must achieve.

Opinion: Lab Shopping is the Achille’s Heel of the US Cannabis Industry

Author: Arun Apte

Journal: Analytical Cannabis, April 05, 2023

Abstract: The legalization of cannabis in various US states has led to the rapid growth of the cannabis industry, which is projected to skyrocket to a whopping $82.3 billion by 2027. The increasing acceptance and legalization of cannabis for both medicinal and recreational use are the key drivers of the industry’s growth.

Cannabis Extraction Facility Setup 101

Author: Martha Hernández

Journal: Cannabis Science and Technology, March 04, 2023

Abstract: This tutorial article outlines the key considerations that must be put in place when setting up a cannabis extraction facility. The cannabis industry has experienced significant growth momentum in the last decade as several states and countries outside the US have legalized cannabis for medical and recreational use.

Delineating the Nuts and Bolts of the USDA’s Hemp Testing Rules

Author: Martha Hernández

Journal: Cannabis Science and Technology, January/February 2023

Abstract: Hemp was legalized federally in the U.S. when the 2018 Farm Bill was passed. However, due to the close relationship between hemp which is legal, and cannabis which is not, the hemp industry is strictly regulated by the federal government.

9 Federal Rules You Must Know Before Setting up a Hemp Testing Lab

Author: Martha Hernández

Journal: Labcompare, December 13, 2022

Abstract: Hemp testing is a new and seemingly lucrative niche that several laboratories are looking to venture into. From an economic standpoint, there’s every reason to venture into the industry at this point when the market is still evolving and the economic potential is huge.

Cannabis Extraction Facility Setup: The 7 Success Factors

Author: Martha Hernández

Journal: Labcompare, November 8, 2022

Abstract: Setting up a cannabis extraction lab can be an exhilarating experience, especially if you’re passionate about the cannabis industry, because extraction is where all the goodness of cannabis is revealed. The global cannabis extract market was valued at $2.74 billion in 2021 and, with a projected CAGR of 20.6%, it is expected to hit close to $3.5 billion by 2030.1

7 Factors For a Seamless Cannabis Extraction Lab Setup

Author: Martha Hernández

Journal:Analytical Cannabis, October 12, 2022

Abstract:Cannabis extraction and testing have become fundamental pillars supporting the transition of the cannabis industry from an illicit market to a legal one. According to a recent Grandview Research Report, the value of the global cannabis extract market stood at $2.74 billion in 2021. The market is projected to grow at a rate of 20.6% to attain a value of $15.5 billion by 2030.

Starting a Cannabis Extraction Lab? Here Are Some Key Considerations

Author: Martha Hernández

Journal: Cannabis Industry Journal, July 14, 2022

Abstract: Cannabis sativa contains over 500 different bioactive compounds that can be separated through an extraction process. This is carried out in an extraction lab and the end result is the production of cannabis extracts with a high concentration of specific cannabinoids (such as THC or CBD) with up to 99% purity levels.

The USDA's Hemp Testing Rules Have Changed. Are You Ready?

Author: Martha Hernández

Journal: Analytical Cannabis, March 21, 2022

Abstract: Testing is a crucial aspect of the hemp industry; it stamps the legality of hemp in the US. But the testing rules have changed yet again. Is your lab ready to absorb the new requirements?

USDA’s Hemp Testing Rules: Fast Track Your Lab’s Preparedness with Digitization

Author: Martha Hernández

Journal: Cannabis Industry Journal, March 9, 2022

Abstract: Learn about the USDA’s new federal hemp testing rules & how a Laboratory Information Management System (LIMS) can digitize operations to fast-track your lab’s preparedness.

Five Steps to Prepare Cannabis Testing Laboratories for ISO 17025 Audits

Author: Arun Apte

Journal: Cannabis Science and Technology, February 3, 2020

Abstract: This tutorial article outlines some of the steps that cannabis testing laboratories can take to prepare ahead of a third-party safety audit. It discusses several practical measures that facilities can take to boost their chances of passing an audit, including advice on time management, essential employee training, and laboratory management systems that can ensure a smooth and seamless audit process.

Managing Cannabis Testing Lab Workflows using LIMS

Author: Dr. Susan Audino

Journal: Cannabis Industry Journal, February 7, 2018

Abstract: With the increasing legalization of both adult recreational and medical cannabis, there is a need for robust and reliable cannabis analytical testing to ensure consumer safety and drug potency. Cannabis testing laboratories receive high volumes of test requests from cannabis cultivators for testing quantitative and qualitative aspects of the plant.

A Guide to Setting up a Coronavirus (COVID-19) Clinical Diagnostic Testing Laboratory

Author: Shonali Paul

Journal: Clinical Lab Manager, May 29, 2020

Abstract: There is an urgent need to set up new COVID-19 diagnostic testing labs and put procedures in place for existing labs to handle the new COVID-19 testing processes. The Centers for Disease Control and Prevention (CDC) provides specific guidelines on how best to collect, handle and ship COVID-19 specimens. The CDC provides current guidelines related to laboratory biosafety and COVID-19.

Current and Upcoming SARS-CoV-2 Diagnostic Tests: Everything You Need to Know

Author: Shonali Paul

Journal: Lab Manager, May 06, 2020

Abstract: A major challenge concerning the COVID-19 virus is its detection. While the general public is frustrated at the length of time required for COVID-19 testing or developing new test methods, those in the scientific community understand that this is due to the construction of viruses in general, and the logistics of testing thousands of COVID-19 specimens.

FDA Modernization Act 2.0: Accelerate Readiness with an Advanced LIMS Solution

Author: Shonali Paul

Journal: Astrix, September 25, 2025

Abstract: In April 2025, clinical research reached a turning point, with advances reshaping both the science and the regulations that guide it. The FDA unveiled its Roadmap to Reducing Animal Testing in Preclinical Safety Studies, offering a phased strategy for integrating non-animal methods into drug development. Around the same time, the NIH announced the launch of ORIVA—the Office of Research Innovation, Validation,

Boost FDA Modernization Act 2.0 Readiness With an Advanced LIMS

Author: Shonali Paul

Journal: Technology Networks, August 26, 2025

Abstract: April was a remarkable month for both the scientific and regulatory communities in clinical research. The FDA finally set concrete plans for implementing the FDA Modernization Act 2.0, bringing us steps closer to the end of mandatory animal testing in preclinical studies. In the same month, the NIH launched an initiative to prioritize human-based research technologies over animal-based research technologies.

Is Your Food Testing Lab Prepping for an ISO/IEC 17025 Audit?

Author: Arun Apte

Journal: Food Safety Tech, October 20, 2020

Abstract: With the increasing globalization of the food industry, ensuring that products reaching consumers are safe has never been more important. Local, state and federal regulatory agencies are increasing their emphasis on the need for food and beverage laboratories to be accredited to ISO/IEC 17025 compliance. This complicated process can be simplified and streamlined through the adoption of LIMS, making accreditation an achievable goal for all food and beverage laboratories.

Psychedelics 101: The Emergence, Regulatory Framework, & the Need for Quality Testing

Author: Martha Hernández

Journal: Analytical Cannabis, March 15, 2022

Abstract: We live in a world plagued by mental health diseases, which only seem to magnify each year. Conditions like addiction, depression, anxiety, and post-traumatic stress disorder affect a large swath of the population – according to a 2017 study, depression alone affects over 4.4 percent of the global population – and current events like Covid-19 don’t tend to help matters.

Navigating Compliance and Quality Standards Requirements With a LIMS for Water Testing Labs

Author: Arun Apte

Journal: Technology Networks, December 11, 2024

Abstract: Few trends have changed industries in modern history as digital transformation has. From healthcare to manufacturing, every sector is undergoing a shift today, and water testing labs are no different.

Decode Compliance and Quality Standards Requirements with a Water LIMS

Author: Arun Apte

Journal: Astrix, September 16, 2024

Abstract: Water quality directly impacts public health and the environment, which means maintaining stringent standards in water testing is non-negotiable. The stakes are significant, and even a single error can result in substantial fines and may jeopardize public health and safety. For example, failing to comply with regulations like the Clean Water Act (CWA) can lead to hefty fines for each violation. This underscores the critical importance of adhering to complex regulations, such as EPA guidelines, and standards, such as ISO/IEC 17025.

Planning an AI-Driven Lab in 2026? Build a Strong Data Foundation with Smart LIMS Software

Author: Shonali Paul

Journal: Astrix, February 05, 2026

Abstract: As we move into 2026 and beyond, artificial intelligence (AI) is becoming an operational requirement across regulated and non-regulated laboratories alike. From predictive analytics and intelligent quality control to automated decision support,

Key Laboratory KPIs and Lab Metrics Tracking Made Easy with a LIMS

Author: Arun Apte

Journal: Astrix, May 05, 2025

Abstract: You can’t improve what you don’t measure, and this cuts across industries. A recent study found that organizations that use data-driven decision-making are 5–6 times more likely to see major improvements in productivity and performance.

Lab Inventory Management: How to Keep Things Organized

Author: Shonali Paul

Journal: G2, December 11, 2024

Abstract: In the world of laboratories, precision and efficiency are absolute essentials. Yet, inventory mismanagement remains an Achilles’ heel for many labs, often leading to waste, delays, and costly mistakes.

LIMS Data Migration: How to Ace the Journey from Planning to Post-Migration Evaluation

Author: Arun Apte

Journal: Astrix, May 10, 2024

Abstract: Data migration, at its core, appears deceptively simple—a process aimed at transferring data from an old system to a new one. When performed well, labs are better positioned to derive more value from their laboratory information management systems (LIMS) and their data. However, LIMS data migration can be quite complex and risky if not executed correctly.

Is SaaS LIMS Right for Your Laboratory?

Author: Shonali Paul

Journal: Lab Manager, August 26, 2019

Abstract: Software as a service (SaaS) is a term that is not only in vogue now, but every indication is that SaaS applications are here to stay. It wasn’t that long ago that a SaaS application model was met with a high degree of skepticism, and rightly so. A few decades ago, network reliability was at best questionable and companies demanding fast and high-availability of data on distant servers were few and far between.